Cargando…

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

BACKGROUND: Elevated proinflammatory cytokines are associated with greater COVID-19 severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor inhibitor, in patients with severe (requiring supplemental oxygen by nasal cannula or face mask) or critical (requiring greater...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lescure, François-Xavier, Honda, Hitoshi, Fowler, Robert A, Lazar, Jennifer Sloane, Shi, Genming, Wung, Peter, Patel, Naimish, Hagino, Owen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078879/ https://www.ncbi.nlm.nih.gov/pubmed/33676590 http://dx.doi.org/10.1016/S2213-2600(21)00099-0

Ejemplares similares

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
por: Sieper, Joachim, et al.
Publicado: (2015)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
por: Schmidt, Wolfgang A., et al.
Publicado: (2023)

Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
por: Yosipovitch, Gil, et al.
Publicado: (2023)

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2021)

Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial
por: Burmester, Gerd R, et al.
Publicado: (2017)

Sarilumab: Cytomegalovirus colitis: case report
Publicado: (2020)

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
por: van der Heijde, Désirée, et al.
Publicado: (2022)

Randomised, Double Blind, Placebo-Controlled Trial of Echinacea Supplementation in Air Travellers
por: Tiralongo, E., et al.
Publicado: (2012)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
por: Fagerström, Karl, et al.
Publicado: (2010)

Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
por: Li, Yan, et al.
Publicado: (2021)

The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
por: Lion-François, Laurence, et al.
Publicado: (2014)

Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial
por: Han, MeiLan K, et al.
Publicado: (2022)

A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis
por: Allanore, Yannick, et al.
Publicado: (2020)

Sarilumab: patient-reported outcomes in rheumatoid arthritis
por: Crotti, Chiara, et al.
Publicado: (2018)

Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis
por: Xu, Christine, et al.
Publicado: (2019)

Sarilumab: Perforated duodenal ulcer: case report
Publicado: (2021)

Adjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trial
por: Raghuthaman, G., et al.
Publicado: (2015)

Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
por: Dutta, Prosenjit, et al.
Publicado: (2019)

Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
por: Mullen, Michael, et al.
Publicado: (2019)

Palmitoylethanolamide for sleep disturbance. A double-blind, randomised, placebo-controlled interventional study
por: Rao, Amanda, et al.
Publicado: (2021)

Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study
por: Scholey, Andrew, et al.
Publicado: (2010)

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)
por: Taylor, Peter C, et al.
Publicado: (2023)

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
por: Fox, Chris, et al.
Publicado: (2012)

Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial
por: Sung, Valerie, et al.
Publicado: (2014)

Use of pethidine for percutaneous liver biopsy – a randomised, placebo-controlled, double blind study
por: Pan, Antony, et al.
Publicado: (2015)

TRYMS: the ethical and practical considerations of a double-blind placebo controlled randomised clinical trial
por: Swain, Jayne, et al.
Publicado: (2015)

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
por: Yanakieva, Steliana, et al.
Publicado: (2018)

Multicentre randomised double-blinded placebo-controlled trial of favipiravir in adults with mild COVID-19
por: Bosaeed, Mohammad, et al.
Publicado: (2021)

Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial
por: van Beers, Martijn, et al.
Publicado: (2021)

Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial
por: Abbar, Mocrane, et al.
Publicado: (2022)

The effect of zinc supplementation on glucose homeostasis: a randomised double-blind placebo-controlled trial
por: Attia, John R., et al.
Publicado: (2022)

Drotaverine to shorten the duration of labour in primigravidas: a randomised, double-blind, placebo-controlled trial
por: Ikeotuonye, Arinze Chidiebele, et al.
Publicado: (2022)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial
por: Yamada, Hideto, et al.
Publicado: (2022)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
por: Reginster, Jean-Yves, et al.
Publicado: (2013)

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment
por: Genovese, Mark C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pboetrgm9rmjkhk1db6kr0r34k